Anixa Biosciences (ANIX) Minority Interest (2018 - 2026)
Anixa Biosciences' (ANIX) quarterly Minority Interest came in at -$1.3 million in Q2 2026, down 7.66% YoY from -$1.4 million in Q2 2025, and down 3.3% on a QoQ basis from -$1.2 million in Q4 2025.
Anixa Biosciences (ANIX) Minority Interest (2018 - 2026) Analysis & Trends
Anixa Biosciences (ANIX) has 9 years of Minority Interest data on file, last reported at -$1.3 million in Q2 2026.
- Quarterly Minority Interest fell 7.66% year-over-year to -$1.3 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$1.3 million (down 7.66% YoY) and the FY2025 annual result came in at -$1.2 million, down 9.1% from the prior year.
- Minority Interest fell to -$1.3 million in Q2 2026, from -$1.2 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of -$721000.0 in Q1 2022 to a low of -$1.3 million in Q2 2026.
- A 5-year average of -$999117.6 and a median of -$1.0 million in 2024 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2022 — Minority Interest tumbled 38.37% — and 2026, when it retreated 7.66%.
- Tracing ANIX's Minority Interest over 5 years: stood at -$847000.0 in 2022, then fell by 14.05% to -$966000.0 in 2023, then dropped by 14.91% to -$1.1 million in 2024, then decreased by 9.1% to -$1.2 million in 2025, then decreased by 3.3% to -$1.3 million in 2026.
- The last three Minority Interest figures came in at -$1.3 million (Q2 2026), -$1.2 million (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Anixa Biosciences | 124.46 Mn | 124.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.25 Mn |
| Oct 31, 2025 | -1.21 Mn |
| Jul 31, 2025 | -1.18 Mn |
| Apr 30, 2025 | -1.16 Mn |
| Jan 31, 2025 | -1.14 Mn |
| Oct 31, 2024 | -1.11 Mn |
| Jul 31, 2024 | -1.08 Mn |
| Apr 30, 2024 | -1.04 Mn |
| Jan 31, 2024 | -1.00 Mn |
| Oct 31, 2023 | -966,000.00 |
| Jul 31, 2023 | -935,000.00 |
| Apr 30, 2023 | -898,000.00 |
| Jan 31, 2023 | -879,000.00 |
| Oct 31, 2022 | -847,000.00 |
| Jul 31, 2022 | -794,000.00 |
| Apr 30, 2022 | -765,000.00 |
| Jan 31, 2022 | -721,000.00 |
| Oct 31, 2021 | -671,000.00 |
| Jul 31, 2021 | -612,728.00 |
| Apr 30, 2021 | -559,107.00 |